GE HealthCare Technologies Inc.
US ˙ NasdaqGS ˙ US36266G1076

SecurityGEHC / GE HealthCare Technologies Inc.
InstitutionHighPoint Advisor Group LLC
Latest Disclosed Ownership17,419 shares
Latest Disclosed Value $ 1,239,919
HighPoint Advisor Group LLC reports 11.00% decrease in ownership of GEHC / GE HealthCare Technologies Inc.

On May 14, 2026 - HighPoint Advisor Group LLC filed a 13F-HR form disclosing ownership of 17,419 shares of GE HealthCare Technologies Inc. (US:GEHC) valued at $1,239,884 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 14, 2026 disclosing 19,572 shares of GE HealthCare Technologies Inc.. This represents a change in shares of -11.00% during the quarter. The current value of the position is $1,126,487 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F GE HEALTHCARE Common Stock 36266G107 17,419 -2,153 -11.00 1,240 -22.80 0.0520
2026-05-14 2025-12-31 13F/A-2 GE HEALTHCARE Common Stock 36266G107 19,572 -13,860 -41.46 1,605 -36.06 0.0671
2026-02-04 2025-12-31 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 32,755 -677 2,687 0.1246
2025-11-05 2025-09-30 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 33,432 -16,670 -33.27 2,511 -32.36 0.1196
2025-08-07 2025-06-30 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 50,102 17,509 53.72 3,711 67.24 0.1972
2025-05-05 2025-03-31 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 32,593 -4,547 -12.24 2,219 -27.63 0.1292
2025-02-12 2024-12-31 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 37,140 -380 -1.01 3,067 -12.92 0.1666
2024-11-04 2024-09-30 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 37,520 -15,289 -28.95 3,521 87,925.00 0.2053
2024-08-08 2024-06-30 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 52,809 38,028 257.28 4 300.00 0.2606
2024-05-14 2024-03-31 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 14,781 1,771 13.61 1 -99.91 0.0846
2024-03-26 2023-12-31 13F GE HEALTHCARE TECHNOLOGIES Common Stock 36266G107 13,010 13,010 1,149 0.0823
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.